These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 2956229

  • 1. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
    Carper HT, Sullivan GW, Mandell GL.
    J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P, Joly P.
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    Klastersky J, Van der Auwera P.
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC, Simon M.
    Scand J Infect Dis Suppl; 1990 Mar; 72():14-9. PubMed ID: 2151061
    [Abstract] [Full Text] [Related]

  • 9. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT.
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [Abstract] [Full Text] [Related]

  • 10. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [Abstract] [Full Text] [Related]

  • 11. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F.
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [Abstract] [Full Text] [Related]

  • 12. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A, Cassone M, Monaco M, Tarasi D, Pompeo ME, Venditti M.
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S, Brumfitt W, Hamilton-Miller JM.
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [Abstract] [Full Text] [Related]

  • 14. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ, Saravolatz LD, Somerville MM.
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [Abstract] [Full Text] [Related]

  • 15. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Cabellos C, Garrigós C, Taberner F, Force E, Pachón-Ibañez ME.
    J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
    [Abstract] [Full Text] [Related]

  • 16. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Pavie J, Lefort A, Ploy MC, Massias L, Chau F, Garry L, Denis F, Fantin B.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
    [Abstract] [Full Text] [Related]

  • 17. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin.
    Norden CW, Niederreiter K, Shinners EM.
    Infection; 1986 Jun; 14(3):136-8. PubMed ID: 2942488
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K.
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.
    Yzerman EP, Boelens HA, Vogel M, Verbrugh HA.
    J Antimicrob Chemother; 1998 Aug; 42(2):233-9. PubMed ID: 9738842
    [Abstract] [Full Text] [Related]

  • 20. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L, De Vecchi E, Nicola L, Gismondo MR.
    BMC Infect Dis; 2007 Sep 21; 7():111. PubMed ID: 17888153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.